Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 5Breast Neoplasms 5Sarcoma 3Lymphoma, Mantle-Cell 3Lymphoma, Follicular 3Carcinoma, Renal Cell 3Wilms Tumor 2Unspecified Adult Solid Tumor, Protocol Specific 2Testicular Neoplasms 2Teratoma 2Squamous Cell Carcinoma of Head and Neck 2Salivary Gland Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Ovarian Neoplasms 2Osteosarcoma 2Neuroectodermal Tumors, Primitive, Peripheral 2Neuroblastoma 2Lymphoma, Non-Hodgkin 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia 2Kidney Neoplasms 2Central Nervous System Neoplasms 2Carcinoma, Ovarian Epithelial 2Burkitt Lymphoma 2Breast Neoplasms, Male 2Astrocytoma 2

Interventions

Filgrastim 7plerixafor 2Etoposide 2Cyclosporine 2Cyclophosphamide 2pegfilgrastim 1ixabepilone 1Voriconazole 1Vincristine 1Tretinoin 1Topotecan 1Thioguanine 1Radiotherapy 1Psychiatric Rehabilitation 1Phenobarbital 1Peripheral Blood Stem Cell Transplantation 1Mitoxantrone 1Levofloxacin 1Lenalidomide 1Irinotecan 1Ifosfamide 1Idarubicin 1Granulocyte-Macrophage Colony-Stimulating Factor 1Granulocyte Colony-Stimulating Factor 1Doxorubicin 1Daunorubicin 1Cytarabine 1Clofarabine 1Ciprofloxacin 1Cefepime 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Neutropenia × ixabepilone × Clear all
NCT00020371 2024-03-04

BMS-247550 in Treating Patients With Cancers That Have Not Responded to Previous Therapy

National Cancer Institute (NCI)

Phase 1 Completed

Neoplasms, Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡